VTGN vs XBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

VTGN

30.9
AI Score
VS
XBIO Wins

XBIO

57.7
AI Score

Investment Advisor Scores

VTGN

31score
Recommendation
SELL

XBIO

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VTGN XBIO Winner
Revenue 354,000 1.47M XBIO
Net Income -7.75M -1.39M XBIO
Net Margin -2187.9% -94.5% XBIO
Operating Income -7.75M -1.47M XBIO
ROE -9.0% -22.8% VTGN
ROA -7.5% -19.9% VTGN
Total Assets 103.91M 6.97M VTGN
Current Ratio 15.93 7.43 VTGN

Relative Price Performance (Last 90 Days)

VTGN 1M: +14.2% · 3M: +14.3% XBIO 1M: -47.3% · 3M: -21.4%

Current Technical Phase

VTGN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.5 · Price: $0.28

XBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.8 · Price: $2.24

Fundamentals Snapshot

Metric VTGN XBIO
Market Cap — —
Forward P/E -0.3 -6.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 5.0% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin -9.0% -1.5%
EPS -1.54 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.